🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

¡La nueva moneda de 2€ va a ser sobre Salamanca! 😍 ¡La Fábrica Nacional de Moneda y Timbre hará este año 2025 una emisión de 2 millones de monedas 💶 dedicada a la Ciudad Vieja de Salamanca! ❤️ Patrimonio Mundial de la UNESCO 🏛⛪️ Entérate de +eventos: conciertosensalamanca.com

🔝Nice 7q deletion detected in PB limphocytosis

🚨 Exciting news from IACH! In celebration of Myeloma Awareness Month, we are proud to present 🩸the IACH Multiple Myeloma Academy A groundbreaking initiative designed to advance, education, collaboration, and innovation in the field of #MultipleMyeloma As treatment

📢 Emergencies in Hematology: Why, When, and How I Treat? 🔬🩸 📄 Reference: Duminuco, A. et al. J. Clin. Med. 2024, 13, 7572. 🔗 DOI: 10.3390/jcm13247572 🆘 Hematologic Emergencies require immediate intervention 🚑 due to their rapid progression ⚡ & life-threatening risks ☠️.

Un nuevo estudio analizó el riesgo de padecer cáncer hematológico en pacientes con diabetes tipo dos que tomaron distintas medicinas: insulina, metformina, Ozempic, etc. Los resultados fueron fascinantes. Esto fue lo que encontraron…

Welcome to an EHA #LearningMondays challenge! This week's question was submitted by Dr Denis Cetin, Ege University Hospital, Turkey. Considering his medical results, what is the best treatment for this patient? ✏️Submit your answer and receive immediate feedback in our form:

How I Treat Secondary AML (sAML) Based on: Green and Wang, Blood, 2024 DOI: 10.1182/blood.2024024011 ⸻ 🧬 Secondary AML = poor-risk phenotype Origins: •🔬 MDS → AML-MR / ts-AML •☢️ Chemo/Radiation/PARPi → AML-pCT •🧪 MPN → MPN-BP 🧪 Fit patients •AML-MR: CPX-351,

Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL) nature.com/articles/s4137…

My 2 Cents Worth On Thrombophilia Screening Credit UpToDate HaemBytes #medicine #hematology #meded #medtwitter

How I treat AML relapse after allogeneic HSCT ashpublications.org/blood/article-… #AML #leusm

📊#CD3xCD20 #Bispecifics in #Lymphoma 🧬Mosunetuzumab: FL ORR80%, CR 60% | DLBCL ORR42%, CR 24% 🧬Glofitamab: FL ORR 81%, CR 70% | DLBCL ORR 52%, CR 39% 🧬Epcoritamab: FL ORR 82%, CR 63% | DLBCL ORR 63%, CR 39% 🧬Odronextamab: FL ORR 80%, CR 73% | DLBCL ORR 52%, CR 31% 💡for R/R

🧵 #MultipleMyeloma 2025 Mayo Clinic Flowcharts Summary 🩸🧬 By Dr. S. Vincent Rajkumar #MM #Oncology #ASCT #Bispecifics #Hematology 🧪 ⸻ 1️⃣ Newly Diagnosed, Transplant-Eligible 💠 Standard-Risk → Induction: Dara-VRd or Isa-VRd x 3–4 → Early ASCT or Stem cell cryo + 4–5 more

Internist to fellowship: a path to success - The Lancet Haematology “My time as an internist was indispensable…” thelancet.com/journals/lanha…

📣 The second edition of the EU CAR-T Handbook is here to advance clinical practice and education 📣 💡 Jointly developed by EBMT, European Hematology Association, and the GoCART_Coalition, it is a comprehensive, open-access resource covering the latest developments in the field of CAR-T — a

🎉𝗖𝗼𝗻𝗴𝗿𝗮𝘁𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗣𝗿𝗼𝗳. 𝗠𝗮𝗿𝗶́𝗮-𝗩𝗶𝗰𝘁𝗼𝗿𝗶𝗮 𝗠𝗮𝘁𝗲𝗼𝘀 𝘚𝘩𝘦 𝘩𝘢𝘴 𝘣𝘦𝘦𝘯 𝘢𝘸𝘢𝘳𝘥𝘦𝘥 𝘵𝘩𝘦 𝗪𝗮𝗹𝗱𝗲𝗻𝘀𝘁𝗿𝗼̈𝗺 𝗟𝗶𝗳𝗲𝘁𝗶𝗺𝗲 𝗔𝗰𝗵𝗶𝗲𝘃𝗲𝗺𝗲𝗻𝘁 𝗔𝘄𝗮𝗿𝗱 𝘛𝘩𝘪𝘴 𝘢𝘸𝘢𝘳𝘥 𝘪𝘴 𝘨𝘪𝘷𝘦𝘯 𝘵𝘰 𝘢 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩𝘦𝘳

1/7 Origins of the Clotting Cascade: Divine Intervention or Natural Selection? Ok, ok it is a rhetorical question, but an entertaining one, nonetheless. Some creationists argue that the clotting cascade is irreducibly complex, too intricate to have evolved step by step.

Cuando sales de un lugar al que no perteneces y comienzas a ser quien realmente ERES.